Balaji Amines Valuation Multiples

Balaji Amines is valued at $659M as of October 2026, a 3.8x revenue multiple. In the last 12 months, Balaji Amines revenue was $175M and Balaji Amines EBITDA was $30M.

Balaji Amines Overview

About Balaji Amines

Balaji Amines makes methylamines, ethylamines, derivatives and specialty chemicals used in pharma, agrochemicals, solvents and polymers. It is among the largest producers of aliphatic amines in India and sells to industrial buyers at home and abroad. Plants are in Maharashtra, Telangana and Karnataka. It is based in Solapur.


Founded

1988

HQ

India

Employees

1.3K

Sectors

Financials (LTM)

Revenue: $175M
EBITDA: $30M

EV

$663M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Balaji Amines Financials

Balaji Amines reported last 12-month revenue of $175M and EBITDA of $30M.

In the same LTM period, Balaji Amines generated $30M in EBITDA and $20M in net income.


Balaji Amines P&L

In the most recent fiscal year, Balaji Amines reported revenue of $148M and EBITDA of $29M.

Balaji Amines is profitable as of last fiscal year, with gross margin of 42%, EBITDA margin of 20%, and net margin of 12%.

See analyst estimates for Balaji Amines
LTMLast FY202320242025202620272028
Revenue$175M$148M$189M$152M$148M
Gross Profit-$61M$83M$65M$62M
Gross Margin-42%44%43%42%
EBITDA$30M$29M$42M$28M$28M
EBITDA Margin17%20%22%18%19%
EBIT Margin12%15%20%14%15%
Net Profit$20M$18M$25M$18M$17M
Net Margin12%12%13%12%12%
Net Debt-$6M---

Financial data powered by Morningstar, Inc.

Balaji Amines Stock Performance

Balaji Amines has current market cap of $659M, and enterprise value of $663M.


Balaji Amines' stock price is $20.32.

Balaji Amines share price decreased by 8.0% in the last 30 days, and increased by 27.9% in the last year.

Balaji Amines has an EPS (earnings per share) of $0.55.

See more trading valuation data for Balaji Amines
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$663M$659M-3.2%-8.0%-9.2%27.9%$0.55

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Balaji Amines Valuation Multiples

Balaji Amines trades at 3.8x EV/Revenue multiple, and 22.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Balaji Amines

Balaji Amines Financial Valuation Multiples

As of October 22, 2026, Balaji Amines has market cap of $659M and EV of $663M.

Balaji Amines has a P/E ratio of 32.7x.

LTMLast FY202320242025202620272028
EV/Revenue3.8x4.5x3.5x4.4x4.5x
EV/EBITDA22.2x22.6x15.6x23.8x23.3x
EV/EBIT30.3x30.0x17.8x30.1x30.9x
EV/Gross Profit-10.8x8.0x10.2x10.7x
P/E32.7x37.3x26.5x36.8x37.8x
EV/FCFn/m(17.5x)61.5x127.8x(24.4x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Balaji Amines Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Balaji Amines Margins & Growth Rates

Balaji Amines grew revenue by 32% and EBITDA by 4% in the last fiscal year.

In the most recent fiscal year, Balaji Amines reported gross margin of 42%, EBITDA margin of 20%, and net margin of 12%.

See estimated margins and future growth rates for Balaji Amines

Balaji Amines Margins

Last FY202420252026202720282029
Gross Margin42%43%42%34%
EBITDA Margin20%18%19%17%
EBIT Margin15%14%15%12%
Net Margin12%12%12%11%
FCF Margin(26%)3%(18%)(21%)

Balaji Amines Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth32%(19%)(3%)24%
Gross Profit Growth-(22%)(5%)(0%)
EBITDA Growth4%(34%)2%7%
EBIT Growth-(41%)(3%)3%
Net Profit Growth25%(28%)(3%)21%
FCF Growth-(52%)(624%)39%

Data powered by FactSet, Inc. and Morningstar, Inc.

Balaji Amines Operational KPIs

Balaji Amines' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Balaji Amines' Rule of 40 is 41% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Balaji Amines' Rule of X is 77% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Balaji Amines
LTMLast FY202320242025202620272028
Rule of 4054%41%---
Bessemer Rule of X110%77%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.0M---
S&M Expenses to Revenue-6%5%6%6%
R&D Expenses to Revenue-0%0%0%0%
Opex to Revenue-27%24%28%27%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Balaji Amines Competitors

Balaji Amines competitors include Fineotex Chemical, Braskem, Sharda Cropchem, AECI, Sheela Foam, Krishana Phoschem, SGL Carbon, Explosifs et Produits Chimiques, SK Chemicals and Archean Chemical Industri.

Most Balaji Amines public comparables operate across Chemicals.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Fineotex Chemical$81M$17M8.0x4.4x37.4x27.9x
Braskem$14B$1.3B0.9x0.9x10.3x7.6x
Sharda Cropchem$556M$121M1.0x1.0x4.8x5.1x
AECI$2B$158M0.4x0.4x4.4x3.3x
Sheela Foam$403M$47M1.9x1.8x16.2x16.1x
Krishana Phoschem$170M$33M4.5x-23.3x-
SGL Carbon$955M$51M0.8x0.9x15.2x5.8x
Explosifs et Produits Chimiques$605M$82M1.2x1.1x8.9x8.4x

This data is available for Pro users. Sign up to see all Balaji Amines competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Balaji Amines

When was Balaji Amines founded?Balaji Amines was founded in 1988.
Where is Balaji Amines headquartered?Balaji Amines is headquartered in India.
How many employees does Balaji Amines have?As of today, Balaji Amines has over 1K employees.
Is Balaji Amines publicly listed?Yes, Balaji Amines is a public company listed on Bombay Stock Exchange.
What is the stock symbol of Balaji Amines?Balaji Amines trades under 530999 ticker.
When did Balaji Amines go public?Balaji Amines went public in 2001.
Who are competitors of Balaji Amines?Balaji Amines main competitors include Fineotex Chemical, Braskem, Sharda Cropchem, AECI, Sheela Foam, Krishana Phoschem, SGL Carbon, Explosifs et Produits Chimiques, SK Chemicals, Archean Chemical Industri.
What is the current market cap of Balaji Amines?Balaji Amines' current market cap is $659M.
What is the current revenue of Balaji Amines?Balaji Amines' last 12 months revenue is $175M.
What is the current revenue growth of Balaji Amines?Balaji Amines revenue growth (NTM/LTM) is 37%.
What is the current EV/Revenue multiple of Balaji Amines?Current revenue multiple of Balaji Amines is 3.8x.
What is the current EBITDA of Balaji Amines?Balaji Amines' last 12 months EBITDA is $30M.
What is Balaji Amines' EBITDA margin?Balaji Amines' last 12 months EBITDA margin is 17%.
What is the current EV/EBITDA multiple of Balaji Amines?Current EBITDA multiple of Balaji Amines is 22.2x.
What is the current FCF of Balaji Amines?Balaji Amines' last 12 months FCF is ($1M).
What is Balaji Amines' FCF margin?Balaji Amines' last 12 months FCF margin is (1%).
What is the current EV/FCF multiple of Balaji Amines?Current FCF multiple of Balaji Amines is (601.1x).
How many companies Balaji Amines has acquired to date?Balaji Amines hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Balaji Amines has invested to date?Balaji Amines hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Balaji Amines

Lists including Balaji Amines

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial